相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molnupiravir is effective in patients with haematological malignancies
Lukasz Bolkun et al.
INTERNATIONAL JOURNAL OF CANCER (2023)
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis
Matthew Ho et al.
AMERICAN JOURNAL OF HEMATOLOGY (2023)
Reply to successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients-A Czech multicenter experience: A case series of SARS-CoV-2 Omicron infection and aggressive lymphoma in the Sotrovimab era
Ramona Cassin et al.
HEMATOLOGICAL ONCOLOGY (2023)
Therapeutic advances in COVID-19
Naoka Murakami et al.
NATURE REVIEWS NEPHROLOGY (2023)
Convalescent plasma and COVID-19: Time for a second-second look?
Michael J. Joyner et al.
TRANSFUSION MEDICINE (2023)
Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial
Saoussen Ben Abdallah et al.
CLINICAL INFECTIOUS DISEASES (2023)
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
Queenie Fernandes et al.
ANNALS OF MEDICINE (2022)
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Livio Pagano et al.
BLOOD (2022)
COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research
Lindsey Wang et al.
BLOOD REVIEWS (2022)
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Jennifer Hammond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
R. L. Gottlieb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Pharmacological treatment of COVID-19: an opinion paper
A. Garcia-Lledo et al.
REVISTA ESPANOLA DE QUIMIOTERAPIA (2022)
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
William A. Fischer et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies
Christina Y. Lee et al.
CANCER DISCOVERY (2022)
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
Oskar Ljungquist et al.
INFECTIOUS DISEASES (2022)
Successful treatment with a short course of remdesivir in a case of prolonged COVID-19 in a lymphoma patient
Mikael Kajova et al.
INFECTIOUS DISEASES (2022)
Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
Bartosz Pula et al.
CANCERS (2022)
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
Carlo Visco et al.
BLOOD ADVANCES (2022)
Elements and COVID-19: A Comprehensive Overview of Studies on Their Blood/Urinary Levels and Supplementation with an Update on Clinical Trials
Agnieszka Scibior et al.
BIOLOGY-BASEL (2022)
The outcome of COVID-19 in patients with hematological malignancy
Pinar Tiglioglu et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2022)
COVID-19 vaccination and breakthrough infections in patients with cancer
A. L. Schmidt et al.
ANNALS OF ONCOLOGY (2022)
COVID-19 in patients with hematologic malignancy
Petra Langerbeins et al.
BLOOD (2022)
Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies
Akio Mori et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
Robert Stuver et al.
CANCER CELL (2022)
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
Semih Basci et al.
INTERNAL AND EMERGENCY MEDICINE (2022)
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report
Sabina Chiaretti et al.
HAEMATOLOGICA (2022)
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Anil Gupta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis
Adel Naimi et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
Florence Ader et al.
LANCET INFECTIOUS DISEASES (2022)
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) (Apr, 10.1038/s41375-022-01556-7, 2022)
Georg Maschmeyer et al.
LEUKEMIA (2022)
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19
Myron J. Levin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination
Deniz C. Guven et al.
ONCOLOGIST (2022)
COVID-19 in vaccinated versus unvaccinated hematologic malignancy patients
Catherine DeVoe et al.
TRANSPLANT INFECTIOUS DISEASE (2022)
Molnupiravir and Its Antiviral Activity Against COVID-19
Lili Tian et al.
FRONTIERS IN IMMUNOLOGY (2022)
Convalescent Plasma Therapy, Therapeutic Formulations of Repurposed Drugs in 20th Century Epidemics against COVID-19: A Systematic Review
Diego Fernandez-Lazaro et al.
PHARMACEUTICS (2022)
Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients
M. Veronica Dioverti et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
Ferenc Magyari et al.
ANNALS OF HEMATOLOGY (2022)
Tixagevimab plus Cilgavimab: First Approval
Susan J. Keam
DRUGS (2022)
Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir
Karolina Akinosoglou et al.
VIRUSES-BASEL (2022)
Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma
Yayoi Ueda et al.
INTERNAL MEDICINE (2022)
Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review
Seth Kwabena Amponsah et al.
FRONTIERS IN PHARMACOLOGY (2022)
Association of COVID-19 mortality with serum selenium, zinc and copper: Six observational studies across Europe
Kamil Demircan et al.
FRONTIERS IN IMMUNOLOGY (2022)
COVID-19 in Patients with Hematologic Diseases
Ilaria Carola Casetti et al.
BIOMEDICINES (2022)
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
Hugh Montgomery et al.
LANCET RESPIRATORY MEDICINE (2022)
Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies
Anthony J. Ocon et al.
JOURNAL OF HEMATOLOGY (2022)
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
Jon Salmanton-Garcia et al.
HEMASPHERE (2022)
Viral Clearance with Neutrophil Recovery in a Patient with Active COVID-19 Infection and Refractory Acute Myeloid Leukemia Who Underwent Successful Reinduction with Cytarabine/Idarubicin
Erin A. Dean et al.
CASE REPORTS IN ONCOLOGY (2022)
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano et al.
BLOOD (2022)
Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review
Andrew Ustianowski
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)
Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy
Jerzy Jaroszewicz et al.
CANCERS (2022)
The effect of zinc supplementation on the course of COVID-19-A systematic review and meta-analysis
Monika Olczak-Pruc et al.
ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE (2022)
Use of remdesivir for COVID-19 in patients with hematologic cancer
Alexandra Martin-Onraet et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2022)
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
LANCET (2022)
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study
Sean H. Lim et al.
NATURE CANCER (2022)
Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)
Francesca Romana Mauro et al.
LEUKEMIA (2021)
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper
Ibai Los-Arcos et al.
INFECTION (2021)
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig et al.
LEUKEMIA (2021)
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial
Olivier Hermine et al.
JAMA INTERNAL MEDICINE (2021)
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Joydeb Majumder et al.
AAPS JOURNAL (2021)
Risk factors for severe and critically ill COVID-19 patients: A review
Ya-dong Gao et al.
ALLERGY (2021)
COVID-19 challenges and its therapeutics
Sabi Ur Rehman et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
CAR-T cell therapy and infection: a review
Olivia Bupha-Intr et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
Sylwester Drozdzal et al.
DRUG RESISTANCE UPDATES (2021)
Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies
Silvia Ferrari et al.
LEUKEMIA & LYMPHOMA (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL)
Jennifer A. Whitaker et al.
VACCINE (2021)
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
Takehiro Ura et al.
VACCINE (2021)
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
Viviane C. Veiga et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Livio Pagano et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
Thomas Chatzikonstantinou et al.
LEUKEMIA (2021)
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
Anne Mea Spanjaart et al.
LEUKEMIA (2021)
Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort
Talvinder Bhogal et al.
LEUKEMIA & LYMPHOMA (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies
Preethi Jeyaraman et al.
TRANSFUSION AND APHERESIS SCIENCE (2021)
Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy
Remy Dulery et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
COVID-19 Mechanisms in the Human Body-What We Know So Far
Ashutosh Kumar et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors
Daniele Cattaneo et al.
FRONTIERS IN IMMUNOLOGY (2021)
Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
Alessandro Allegra et al.
FRONTIERS IN IMMUNOLOGY (2021)
Molnupiravir in COVID-19: A systematic review of literature
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
Lindsey E. Roeker et al.
BLOOD (2021)
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
Josep-Maria Ribera et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients
Barbora Weinbergerova et al.
HEMATOLOGICAL ONCOLOGY (2021)
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report
Antonio Cuneo et al.
HEMATOLOGICAL ONCOLOGY (2021)
Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)
Noha Sharafeldin et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
Lixue Huang et al.
LANCET (2021)
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome
Ilana Levy et al.
LEUKEMIA & LYMPHOMA (2021)
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group
Tomas Palanques-Pastor et al.
LEUKEMIA & LYMPHOMA (2021)
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Begin et al.
NATURE MEDICINE (2021)
Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
Maria Teresa Mascellino et al.
INFECTION AND DRUG RESISTANCE (2021)
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
Jason D. Goldman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
Erik Gaitzsch et al.
HEMASPHERE (2021)
Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study
Isabel Regalado-Artamendi et al.
HEMASPHERE (2021)
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections
Rossana Maffei et al.
BLOOD REVIEWS (2020)
Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis
Douglas Tremblay et al.
LEUKEMIA & LYMPHOMA (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Infection in Advanced Chronic Kidney Disease and Subsequent Adverse Outcomes after Dialysis Initiation: A Nationwide Cohort Study
Chih-Hsiang Chang et al.
SCIENTIFIC REPORTS (2020)
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy
Gordon Cook et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Clinical outcome of coronavirus disease 2019 in haemato-oncology patients
James A. Aries et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China
Ruchong Chen et al.
CHEST (2020)
COVID-19 in persons with chronic myeloid leukaemia
Weiming Li et al.
LEUKEMIA (2020)
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)
Evangelos Terpos et al.
LEUKEMIA (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies
Jose Maria Sanchez-Pina et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
Antonio Cuneo et al.
BLOOD (2020)
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience
Vallari Shah et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Infectious Complications of Tyrosine Kinase Inhibitors in Hematological Malignancies
Andrew Kin et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2020)
COVID-19 in patients with hematological malignancies: A retrospective case series
Maria-Stefania Infante et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti et al.
LANCET HAEMATOLOGY (2020)
Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey
Massimo Breccia et al.
LEUKEMIA (2020)
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
Spinello Antinori et al.
PHARMACOLOGICAL RESEARCH (2020)
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)
Giuseppe Lippi et al.
RESPIRATORY MEDICINE (2020)
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
Julio Garcia-Suarez et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Jose Luis Pinana et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
Abi Vijenthira et al.
BLOOD (2020)
Updates in infection risk and management in acute leukemia
C. Logan et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
The use of dexamethasone in the treatment of COVID-19
Mohammed Lester et al.
ANNALS OF MEDICINE AND SURGERY (2020)
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic
Davide Rossi et al.
HEMASPHERE (2020)
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Catherine Cordonnier et al.
LANCET INFECTIOUS DISEASES (2019)
Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia
Vesa Lindstrom et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia
Tamar Tadmor et al.
EXPERT REVIEW OF HEMATOLOGY (2018)
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)
M. Mikulska et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Age and immunity: What is immunosenescence?
Graham Pawelec
EXPERIMENTAL GERONTOLOGY (2018)
Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution
Keith A. Sacco et al.
IMMUNOTHERAPY (2018)
Bacterial Pneumonia in Older Adults
Oryan Henig et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Tyrosine kinase inhibitor (TKI) therapy for newly-diagnosed patients with chronic myeloid leukemia: focusing on TKI discontinuation due to adverse events - is better always good?
Ahmet Emre Eskazan et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies
Waseem Abu-Ashour et al.
BMJ OPEN DIABETES RESEARCH & CARE (2017)
Immune System Dysfunction in the Elderly
Eduardo Fuentes et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2017)
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study
Anat Gafter-Gvili et al.
LEUKEMIA & LYMPHOMA (2016)
An overview of infectious complications after allogeneic hematopoietic stem cell transplantation
Ugur Sahin et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
Risk stratification and immunogenetic risk for infections following stem cell transplantation
Agnieszka Wojtowicz et al.
VIRULENCE (2016)